Clinical Trial Update: Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating Erlotinib, Gemcitabine, and Cisplatin in metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)
• Tarceva (erlotinib)

Snippet

Sponsor: Gyeongsang National University Hospital | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED